BOSTON – Jan. 28, 2026 – David J. Dykeman and Andrew (A.J.) Tibbetts, shareholders in global law firm Greenberg Traurig, LLP, presented on the MassMEDIC webinar “The Future of MedTech: Trends & Opportunities in 2026” live from San Francisco during the J.P. Morgan Healthcare Conference on Jan. 15. Joined by medtech experts Thomas Busby of Mirus Capital Advisors and Irina Ridley of Aerin Medical, Dykeman and Tibbetts discussed financing, mergers and acquisitions, intellectual property, and the transformative role of artificial intelligence (AI) in redefining the future of health care.
Dykeman is co-chair of Greenberg Traurig's Global Life Sciences & Medical Technology Group and co-managing shareholder of the Boston office. He focuses on securing worldwide intellectual property protection and related business strategies for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. He provides strategic patent portfolio development and intellectual property advice for clients, including major research institutions, multinational corporations, and startup companies. He serves on the board of directors of MassMEDIC and previously served on the editorial advisory board for Medical Device & Diagnostic Industry (MD+DI) Magazine. Dykeman was named "Massachusetts Patent Strategy Attorney of the Year" by LMG Life Sciences in 2022.
Tibbetts, an Intellectual Property & Technology shareholder in the firm’s Boston office, leverages prior experience as a software engineer to provide business-oriented intellectual property strategies for software, AI, and electronics-based technologies. He counsels on matters related to software-implemented tech across a range of industries, from networking, fintech, and natural language processing to life sciences, AI, medical records, and medical devices. Tibbetts advises a wide array of clients, ranging from international and publicly traded companies and large research institutions to small and growing companies. He serves on the board of directors of MassMEDIC and HealthTech Build, helping to support digital health efforts in the New England area.